180 related articles for article (PubMed ID: 1327497)
1. Molecular characterization of congenital mesoblastic nephroma and its distinction from Wilms tumor.
Tomlinson GE; Argyle JC; Velasco S; Nisen PD
Cancer; 1992 Nov; 70(9):2358-61. PubMed ID: 1327497
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic abnormalities in mesoblastic nephroma: a link to Wilms' tumour?
Roberts P; Lockwood LR; Lewis IJ; Bailey CC; Batcup G; Williams J
Med Pediatr Oncol; 1993; 21(6):416-20. PubMed ID: 8390601
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor II gene expression by congenital mesoblastic nephroma.
Sharifah NA; Yun K; McLay J
Diagn Mol Pathol; 1995 Dec; 4(4):279-85. PubMed ID: 8634785
[TBL] [Abstract][Full Text] [Related]
4. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
6. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
Cowell JK; Groves N; Baird P
Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
[TBL] [Abstract][Full Text] [Related]
8. A common region of loss of heterozygosity in Wilms' tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5.
Besnard-Guérin C; Newsham I; Winqvist R; Cavenee WK
Hum Genet; 1996 Feb; 97(2):163-70. PubMed ID: 8566947
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
[TBL] [Abstract][Full Text] [Related]
10. Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11.
Radice P; Perotti D; De Benedetti V; Mondini P; Radice MT; Pilotti S; Luksch R; Fossati Bellani F; Pierotti MA
Genomics; 1995 Jun; 27(3):497-501. PubMed ID: 7558032
[TBL] [Abstract][Full Text] [Related]
11. Congenital mesoblastic nephroma: cytogenetic comparison to leiomyoma.
Carpenter PM; Mascarello JT; Krous HF; Kaplan GW
Pediatr Pathol; 1993; 13(4):435-41. PubMed ID: 8396768
[TBL] [Abstract][Full Text] [Related]
12. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes.
Yeger H; Cullinane C; Flenniken A; Chilton-MacNeil S; Campbell C; Huang A; Bonetta L; Coppes MJ; Thorner P; Williams BR
Cell Growth Differ; 1992 Dec; 3(12):855-64. PubMed ID: 1335280
[TBL] [Abstract][Full Text] [Related]
13. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
14. Cellular congenital mesoblastic nephroma in a newborn.
Schmidt D; Harms D; Lehner-Geisser M
Pathol Res Pract; 1984 Nov; 179(2):242-9. PubMed ID: 6097889
[TBL] [Abstract][Full Text] [Related]
15. Congenital mesoblastic nephroma: report of a case.
Kuo CY; Tsau YK; Yau KI; Chuang SM
Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):836-8. PubMed ID: 2556493
[TBL] [Abstract][Full Text] [Related]
16. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
Waber PG; Chen J; Nisen PD
Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
[TBL] [Abstract][Full Text] [Related]
18. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor.
Gerald WL; Gramling TS; Sens DA; Garvin AJ
Am J Pathol; 1992 May; 140(5):1031-7. PubMed ID: 1316081
[TBL] [Abstract][Full Text] [Related]
19. Genomic imprinting and Wilms' tumor.
Moulton T; Chung WY; Yuan L; Hensle T; Waber P; Nisen P; Tycko B
Med Pediatr Oncol; 1996 Nov; 27(5):476-83. PubMed ID: 8827077
[TBL] [Abstract][Full Text] [Related]
20. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]